Biofrontera Inc. Interest Expense
Biofrontera Inc. (BFRI) reported Interest Expense of $620.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-08-14
- Biofrontera Inc. interest expense for the quarter ending 2024-06-30 was $620.00K, a 1837.50% increase year-over-year.
- Biofrontera Inc. interest expense for the quarter ending 2024-03-31 was $1.42M, a 70950.00% increase year-over-year.
- Biofrontera Inc. interest expense for the quarter ending 2023-12-31 was -$36.00K.
- Biofrontera Inc. interest expense for the quarter ending 2023-09-30 was $142.00K, a 59.55% increase year-over-year.
- Biofrontera Inc. interest expense for fiscal 2023 was $220.00K, a 1733.33% increase from fiscal 2022.
- Biofrontera Inc. interest expense for fiscal 2022 was $12.00K.
- Biofrontera Inc. interest expense for fiscal 2020 was $2.87M.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-06-30 | $620.00K 10-Q · filed 2024-08-14 | $2.04M 10-Q · filed 2024-08-14 | $2.00M derived: sum of 3 quarters · filed 2024-08-14 | $2.15M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2024-03-31 | $1.42M 10-Q · filed 2024-05-15 | $1.39M derived: sum of 2 quarters · filed 2024-05-15 | $1.53M derived: sum of 3 quarters · filed 2024-05-15 | $1.56M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $106.00K derived: sum of 2 quarters · filed 2024-03-15 | $138.00K derived: sum of 3 quarters · filed 2024-08-14 | $220.00K 10-K · filed 2024-03-15 | |||
| 2023-09-30 | $142.00K 10-Q · filed 2023-11-09 | $174.00K derived: sum of 2 quarters · filed 2024-08-14 | $256.00K 10-Q · filed 2023-11-09 | $28.00K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-06-30 | $32.00K 10-Q · filed 2024-08-14 | $79.00K 10-Q · filed 2023-08-11 | $33.00K 10-Q · filed 2024-08-14 | $114.00K 10-Q · filed 2023-08-11 | -$114.00K derived: sum of 3 quarters · filed 2024-08-14 | -$25.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-15 | -$146.00K derived: sum of 2 quarters · filed 2024-05-15 | -$57.00K derived: sum of 3 quarters · filed 2024-05-15 | -$19.00K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$59.00K derived: sum of 2 quarters · filed 2024-03-15 | -$21.00K derived: sum of 3 quarters · filed 2024-03-15 | $12.00K 10-K · filed 2024-03-15 | $195.00K 10-K · filed 2023-03-13 | ||
| 2022-09-30 | $89.00K 10-Q · filed 2023-11-09 | $127.00K derived: sum of 2 quarters · filed 2023-11-09 | $160.00K 10-Q · filed 2023-11-09 | $220.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $38.00K 10-Q · filed 2023-08-11 | $71.00K 10-Q · filed 2023-08-11 | $131.00K derived: sum of 3 quarters · filed 2023-10-03 | $217.00K derived: sum of 4 quarters · filed 2023-10-03 | |||
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-12 | $33.00K 10-Q · filed 2022-05-13 | $93.00K derived: sum of 2 quarters · filed 2023-10-03 | $179.00K derived: sum of 3 quarters · filed 2023-10-03 | $264.00K derived: sum of 4 quarters · filed 2023-10-03 | ||
| 2021-12-31 | $89.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $175.00K derived: sum of 2 quarters · filed 2023-10-03 | $260.00K derived: sum of 3 quarters · filed 2023-10-03 | $344.00K 8-K · filed 2023-10-03 | |||
| 2021-09-30 | $86.00K 10-Q · filed 2022-11-14 | $171.00K derived: sum of 2 quarters · filed 2022-11-14 | $255.00K 10-Q · filed 2022-11-14 | $1.01M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $85.00K 10-Q · filed 2022-08-12 | $169.00K 10-Q · filed 2022-08-12 | $925.00K derived: sum of 3 quarters · filed 2022-08-12 | $1.67M derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $84.00K 10-Q · filed 2022-05-13 | $840.00K derived: sum of 2 quarters · filed 2022-05-13 | $1.58M derived: sum of 3 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $756.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $1.50M derived: sum of 2 quarters · filed 2022-04-11 | $2.87M 10-K · filed 2022-04-11 | ||||
| 2020-09-30 | $744.00K 10-Q · filed 2021-11-30 | $2.11M 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |